Increasing data show that FTO as an m6A demethylase plays an oncogenic role in acute myeloid leukemia [43], breast cancer [44] and melanoma [45], but restrains ovarian cancer stem cell self-renewal [46]. This evidence concerns the gene FTO and breast carcinoma.